Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages

Mariana P Socal; Matthew A Crane; Gerard F Anderson

doi:10.1001/jama.2024.5296

Global Production of Active Pharmaceutical Ingredients for US Generic Drugs Experiencing Shortages

JAMA. 2024 May 28;331(20):1763-1765. doi: 10.1001/jama.2024.5296.

Authors

Mariana P Socal¹, Matthew A Crane², Gerard F Anderson¹

Affiliations

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² Johns Hopkins University School of Medicine, Baltimore, Maryland.

PMID: 38683587
PMCID: PMC11059038 (available on 2024-10-29)
DOI: 10.1001/jama.2024.5296

No abstract available

Plain language summary

This study evaluates the characteristics of generic active pharmaceutical ingredients (APIs) used to manufacture drugs with shortages in the US and facilities producing APIs worldwide.

Publication types

News
Research Support, Non-U.S. Gov't

MeSH terms

Bulk Drugs
Drug Industry*
Drugs, Generic* / economics
Drugs, Generic* / supply & distribution
Humans
United States

Substances

Drugs, Generic
Bulk Drugs